6Vuorela AL,Ahonen A.Preoperative stereotactic hookwire localization of nonpalpable breast lesions with and withort the use of a further stereotsctic check film[J].Anticancer Res.2000,20:1277-1279.
7Maganini RO,Klem DA,Huston BJ,et al.Upgrade rate of core biopsydetermined atypical ductal hyperplasia by open excisional biopsy[J].Am J Surg,2001,182:355 -358.
2Staradub VL, Hsieh YC, Clanson J,et al. Factors that influence surgical choices in women with breast carcinoma. Cancer, 2002,95: 1185-1190.
3Monsfield CM. Intraoperative Ir-192 implantation for early breast cancer: techniques and results. Cancer, 1990,66:1-4.
4Veronesi U, Salvadofi B, Luini A, et al. Conservative treatment of early breast cancer: long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy. Ann Surg,1990,211:250-259.
5Beck NE, Bradburn M J, Vincenti AC, et al. Detection of residual disease following breast-conserving surgery. Br J Surg, 1998, 85:1273-1276.
6Jacobson JA, Danforth DN, Cowan KH, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage Ⅰ and Ⅱ breast cancer. N Engl J Med, 1995,332: 907-911.
7Guadagnoli E, Weeks JC, Shapiro CL, et al. Use of breast-conserving surgery for treatment of stage Ⅰ and stage Ⅱ breast cancer. J Clin Oncol. 1998.16:101-106.
8McMasters KM, Giuliano AE, Ross MI, et al. Sentinel-lymph-node biopsy for breast cancer-not yet the standard of care. N Engl J Med, 1998, 339:990-993.
9Freeman ME, Kanyicska B, Lerant A, et al. Prolactin: structure, function, and regulation of secretion. Physiol Rev, 2000; 80:1523 - 1631.
10Clevenger CV, Furth PA, Hankinson SE, et al. The role of prolactin in mammary carcinoma. Endoer Rev, 2003 ; 24(1) : 1 - 27.
